-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shisi Pharmaceutical Obtains Another Invention Patent
Category:
发布时间：2020-03-21
【概要描述】
Recently, the research achievement “A Sofosbuvir Tablet and Its Preparation Method,” independently developed by Shijiazhuang Sihua Pharmaceutical Co., Ltd., was granted a patent by the China National Intellectual Property Administration.
Recently, the research achievement “A Sofosbuvir Tablet and Its Preparation Method,” independently developed by Shijiazhuang Sihua Pharmaceutical Co., Ltd., was granted a patent by the China National Intellectual Property Administration.
This invention provides a sofosbuvir tablet and a method for its preparation. Compared with the prior art, it significantly enhances the dissolution of the sofosbuvir formulation, while also improving manufacturing efficiency, reducing production costs, and enabling scalable industrial production.
Technological innovation is the cornerstone of high-quality enterprise development. In recent years, Shijiazhuang Sihua Pharmaceutical has steadily increased its investment in research and development, continuously upgraded its R&D innovation platforms, and actively refined its related management systems, thereby stimulating the innovative enthusiasm of its research teams. As a result, the number of patents held has continued to rise; to date, the company has been granted a total of 79 patents, including 47 invention patents and 27 utility model patents. These intellectual property achievements provide robust technological support for product optimization, market expansion, and the enhancement of the company’s core competitiveness.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091